Medical Devices Saudi Arabia

Saudi Arabia Carrier Screening Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Saudi Arabia Carrier Screening Market Industry Trends and Forecast to 2034: Segmented by (Test, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Saudi Arabia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $41.0 Mn Placeholder estimate
Estimate 2025 $46.3 Mn 1.6% of the global market
Projected 2034 $137.9 Mn 198% Adds $91.6 Mn over 9 forecast years
CAGR 2025–2034 12.9% Faster than 69% of 173 Medical Devices markets here
Key players 5
  • Saudi Arabia is 1.56% of the global market.
  • In Middle East, the largest is Saudi Arabia (this report) at $46.3 Mn.
  • Fastest growing: Saudi Arabia (this report) at 12.9% a year.
  • Saudi Arabia ranks 1st of 2 by size in Middle East.

Market size projection

Saudi Arabia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$91.6 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Carrier Screening Market market size by year, Saudi Arabia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $41.0 Mn — —
2025 (base) $46.3 Mn +$5.3 Mn —
2026 (forecast) $52.2 Mn +$6.0 Mn +12.9%
2027 (forecast) $59.0 Mn +$6.7 Mn +27.5%
2028 (forecast) $66.6 Mn +$7.6 Mn +43.9%
2029 (forecast) $75.2 Mn +$8.6 Mn +62.5%
2030 (forecast) $84.9 Mn +$9.7 Mn +83.4%
2031 (forecast) $95.8 Mn +$10.9 Mn +107.1%
2032 (forecast) $108.2 Mn +$12.4 Mn +133.8%
2033 (forecast) $122.1 Mn +$14.0 Mn +164%
2034 (forecast) $137.9 Mn +$15.8 Mn +198%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Saudi Arabia Carrier Screening Market Analysis at a glance
Market size, 2025$46.3 Mn placeholder estimate
Forecast, 2034$137.9 Mn placeholder estimate
Growth (CAGR), 2025–203412.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, condition and end user (see all)
Key playersMyriad Genetics, Inc., Natera, Invitae, Sema4 (GeneDx), Fulgent Genetics (see all)
Regulator in Saudi ArabiaSFDASource: Saudi Food and Drug Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Saudi Arabia Carrier Screening Market Analysis Executive Summary

Carrier screening checks future parents for gene changes they could pass on, such as for cystic fibrosis or spinal muscular atrophy.

Key segments of the carrier Screening market include test (Expanded Panels and Targeted Screening) and condition (Cystic Fibrosis, SMA and Thalassemia).

Bar chart: Saudi Arabia Carrier Screening market size, 2024–2034, placeholder estimates. $41.0 Mn in 2024, $46.3 Mn in 2025 and $137.9 Mn in 2034, 12.9% CAGR.
Saudi Arabia Carrier Screening market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Saudi Arabia Carrier Screening Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the carrier Screening market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the carrier Screening market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the carrier Screening market.

Competitive Landscape for Carrier Screening Market in Saudi Arabia

The carrier Screening market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Carrier Screening Market in Saudi Arabia

Carrier Screening in Saudi Arabia: rules and payment

Medical devices need marketing authorisation from the Saudi Food and Drug Authority (SFDA).⁠[1] Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI).⁠[2]

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Council of Health Insurance. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how carrier Screening products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Saudi Arabia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Carrier Screening right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Carrier Screening in context

Saudi Arabia compared

  • Health spending per person: 1,825 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 3.41 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). Highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 3.1% of people (2025). World: 10.4% of people (2025). 6th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 17 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Carrier Screening market in Saudi Arabia?
Placeholder estimate: about $46.3 Mn in 2025, rising to about $137.9 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Carrier Screening market in Saudi Arabia growing?
Placeholder estimate: about 12.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Carrier Screening market report cover?
The report splits the market by test (Expanded Panels, Targeted Screening), condition (Cystic Fibrosis, SMA, Thalassemia, Fragile X) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Carrier Screening market?
Key players include Myriad Genetics, Inc., Natera, Invitae, Sema4 (GeneDx) and Fulgent Genetics.
What is driving the Carrier Screening market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the carrier Screening market.
Who regulates Carrier Screening in Saudi Arabia?
Medical devices need marketing authorisation from the Saudi Food and Drug Authority (SFDA). Source: Saudi Food and Drug Authority. Checked 14 Nov 2026.
How is healthcare paid for in Saudi Arabia?
Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI). Source: Council of Health Insurance. Checked 14 Nov 2026.
How much research is published on Carrier Screening?
PubMed lists 837 papers on Carrier Screening added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Saudi Arabia

See all

Related on genomics and maternal

See the topic